Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) SHH

Currency In CNY

AD

Valuation

Market Cap5.52B
Enterprise Value4.05B
P/E Ratio334.17
PEG Ratio-4.03
Price/Sales Ratio12.82
Price/Book Ratio2.79
Enterprise/Revenue10.36
Enterprise/EBITDA82.83

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue448.37M
Revenue/Share2.94
Gross Profit448.37M
EBITDA35.47M
Net Income46.8M
Diluted EPS0.32

Balance Sheet

Total Cash1.23B
Total Cash/Share7.96
Total Debt100.04M
Total Debt/Equity0.05
Current Ratio10.58
Book Value Per Share13.92

Price History

52-Week Change-11.12
52-Week High50.98
52-Week Low30.4
Moving Average 50 Days38.98
Moving Average 200 Days37.36

Statistics

Average Volume2.33M
Shares Outstanding149.33M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.7
Trailing Annual Dividend Yield1.8
Payout Ratio26.93
Last Split FactorN/A
Last Split DateN/A
AD